Document is current
Any future updates will be listed below
-
Authors
Li, Yang
Imami, Maliha R.
Zhao, Linmei
Amindarolzarbi, Alireza
Mena, Esther
Leal, Jeffrey
Chen, Junyu
Gafita, Andrei
Voter, Andrew F.
Li, Xin
Du, Yong
Zhu, Chengzhang
Choyke, Peter L.
Zou, Beiji
Jiao, Zhicheng
Rowe, Steven P.
Pomper, Martin G.
Bai, Harrison X.
-
Funding
Funding for this research was provided by:
NIH/NCI (U01CA140204)
R01 (CA134675)
T32 (T32EB006351)
P41 (EB024405)
- License Information
-
More Information
Article History
Received: 22 January 2024
Revised: 22 January 2024
Accepted: 26 March 2024
First Online: 8 April 2024
Declarations
:
: M.G.P. is co-inventor on a US patent covering <sup>18</sup>F-DCFPyL and as such is entitled to a portion of any licensing fees and royalties generated by this technology. The arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. S.P.R. is a consultant to Progenics Pharmaceuticals, the licensee of <sup>18</sup>F-DCFPyL. M.G.P and S.P.R receive research funding from Progenics Pharmaceuticals. No other potential conflicts of interest relevant to this article exist.
